Molenkamp, Barbara G <br/><br/>
Local administration of PF-3512676 CpG-B instigates tumor-specific CD8+ T-cell reactivity in melanoma patients.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Jul 2008 
 - 4532-42 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-07-4711  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antigens, Neoplasm--immunology<br/>CD8-Positive T-Lymphocytes--immunology<br/>Chemotherapy, Adjuvant<br/>Dendritic Cells--cytology<br/>Flow Cytometry<br/>Humans<br/>Immunotherapy, Active--methods<br/>Injections, Intralesional<br/>Killer Cells, Natural--cytology<br/>Melanoma--drug therapy<br/>Middle Aged<br/>Neoadjuvant Therapy<br/>Oligodeoxyribonucleotides--administration & dosage<br/>Sentinel Lymph Node Biopsy<br/>Skin Neoplasms--drug therapy